Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -2.18
- Piotroski Score 2.00
- Grade Buy
- Symbol (ARTL)
- Company Artelo Biosciences, Inc.
- Price $1.12
- Changes Percentage (-0.71%)
- Change -$0.01
- Day Low $1.10
- Day High $1.12
- Year High $1.75
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for prostate and breast cancer treatment, as well as for treating PTSD. Artelo Biosciences, Inc. has research collaboration with Trinity College Dublin to investigate ART27.13 for the treatment of cancer cachexia. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/10/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$3.16
- Trailing P/E Ratio -0.44
- Forward P/E Ratio -0.44
- P/E Growth -0.44
- Net Income $-9,874,000
Income Statement
Quarterly
Annual
Latest News of ARTL
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Justin Hartley Says Jensen Ackles Brings 'Tracker' to the 'Next Level' as They Reunite for Season 2: See the First Look! (Exclusive)
Season 2 of the show "Tracker" reunites longtime friends Hartley and Ackles, with Ackles playing the character Russell. The intense hunt for survivalist Colter in episode 2 brings the friends together...
By PEOPLE.com | 1 day ago -
Resignations aren't startling. They're normal, Adams says.
Mayor Eric Adams is downplaying City Hall resignations amid FBI investigations and his own indictment. He maintains confidence amidst staff changes and legal challenges, projecting stability in the fa...
By POLITICO | 3 days ago -
Is the Sue Gray debacle another Hartlepool moment for Keir Starmer? Let's hope so | Rafael Behr
Labour's leader faced calls to resign after a byelection loss, leading to a staff shakeup at Downing Street. Despite challenges, Keir Starmer aims to steer the government effectively, learning from pa...
By The Guardian | 4 days ago
